Literature DB >> 6188564

Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

S Haahr, A Møller-Larsen, E Pedersen.   

Abstract

A group of multiple sclerosis (MS) patients (n = 50), most of them in a stable or slightly progressive phase was studied together with a group of neurological control (NC) patients with CNS lesions (n = 38) comparable in age and disability and an age matched group of healthy persons (n = 46). On stimulation of lymphocytes with herpes simplex virus (HSV), cytomegalovirus (CMV) and varicella zoster virus (VZV) a significantly lower interferon production was found in MS patients compared with the NC patients and the healthy controls; when the NC patients were compared with the healthy controls a significantly lower production was also found. The lymphocyte transformation reaction in seropositive MS patients was significantly lower than that seen in the seropositive control groups when HSV was used as antigen. Lower responses, although insignificant, were found when CMV and VZV were used as antigens. There were no differences among the three groups when Con A was used as mitogen in three different concentrations. Likewise spontaneous lymphocyte transformations were equal. The lower interferon production and the lower transformation reactions in MS patients could not be correlated to age, duration of disease, disability, disease activity or impairment. No significant differences in humoral immunity to HSV, CMV and VZV were found in the three groups, a few MS patients were 'true' seronegative to HSV type 1 and 2. Suppressor cell activity induced by Con A and measles virus was comparable in the three groups, although a few MS patients in an active relapsing phase were found to have low suppressor cell activity. Natural killer cell activity against two different cell lines was found equal in the three groups, and there was no difference in the potentiating effect of interferon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188564      PMCID: PMC1536881     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Letter: Lack of antigen response to myxoviruses in multiple sclerosis.

Authors:  A K Ciongoli; P Platz; B Dupont; A Svejgaard; T Fog; C Jersild
Journal:  Lancet       Date:  1973-11-17       Impact factor: 79.321

2.  Lymphocyte transformation in multiple sclerosis.

Authors:  M K Jensen
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

Review 3.  The significance of abnormal immune responses in patients with multiple sclerosis.

Authors:  M V Iivanainen
Journal:  J Neuroimmunol       Date:  1981-06       Impact factor: 3.478

4.  Letter: Cellular immunity in multiple sclerosis.

Authors:  H Bartfeld; J A Zaia; H Donnenfeld
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

5.  Letter: Lymphocyte transformation in vitro to paramyxovirus antigens in multiple sclerosis.

Authors:  S Cunningham-Rundles; B Dupont; J B Posner; J A Hansen; R A Good
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

6.  Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.

Authors:  M J Valle; G W Jordan; S Haahr; T C Merigan
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  Measles virus-induced migration inhibition in vitro of leukocytes from patients with multiple sclerosis.

Authors:  H J Nordal; S S Froland; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  Measles virus-induced migration inhibition of human leukocytes in vitro: an expression of cell-mediated immunity?

Authors:  H J Nordal; S S Froland; B Vandvik; E Norrby
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.

Authors:  S Haahr; L Rasmussen; T C Merigan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  A suppression of cellular immunity in patients with multiple sclerosis.

Authors:  V Utermohlen; J B Zabriskie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  3 in total

1.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

2.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

Review 3.  Chronic viral infections of the central nervous system: Aspects specific to multiple sclerosis.

Authors:  P Giraudon; A Bernard
Journal:  Rev Neurol (Paris)       Date:  2009-08-04       Impact factor: 2.607

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.